DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge

Authors

Victoria Gnazzo, Washington University School of Medicine in St. Louis
Hanaa Saleh, Washington University School of Medicine in St. Louis
Ítalo A Castro, Washington University School of Medicine in St. Louis
Adrianus C M Boon, Washington University School of Medicine in St. Louis
Amelia K. Pinto, University of Kentucky
James D Brien, University of Kentucky
Carolina B López, Washington University School of Medicine in St. Louis

Journal

mBio

Publication Date

2-5-2025

Volume

16

Issue

2

First Page

e0358924

Document Type

Open Access Publication

DOI

10.1128/mbio.03589-24

Rights and Permissions

Gnazzo V, Saleh H, Castro ÍA, Boon ACM, Pinto AK, Brien JD, López CB. DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge. mBio. 2025 Feb 5;16(2):e0358924. doi: 10.1128/mbio.03589-24. © 2024 Gnazzo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

Recommended Citation

Gnazzo, Victoria; Saleh, Hanaa; Castro, Ítalo A; Boon, Adrianus C M; Pinto, Amelia K.; Brien, James D; and López, Carolina B, "DDO-adjuvanted influenza A virus nucleoprotein mRNA vaccine induces robust humoral and cellular type 1 immune responses and protects mice from challenge." mBio. 16, 2. e0358924 (2025).
https://digitalcommons.wustl.edu/oa_4/4916

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.